InventisBio Co., Limited (SHA:688382)
China
· Delayed Price · Currency is CNY 23.60
-0.12 (-0.51%)
At close: May 23, 2025, 2:57 PM CST
InventisBio Revenue
InventisBio had revenue of 8.19M CNY in the quarter ending March 31, 2025, a decrease of -4.85%. This brings the company's revenue in the last twelve months to 168.37M, down -13.27% year-over-year. In the year 2024, InventisBio had annual revenue of 168.79M, down -9.02%.
Revenue (ttm)
168.37M
Revenue Growth
-13.27%
P/S Ratio
109.09
Revenue / Employee
910.13K
Employees
185
Market Cap
18.37B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |